, Tracking Stock Market Picks
Enter Symbol:
Durata Therapeutics Inc. (DRTX) [hlAlert]

Neutral DRTX
up 67.06 %

Durata Therapeutics Inc. (DRTX) downgraded to Neutral with price target $23 by ROTH Capital

Posted on: Wednesday,  Oct 15, 2014  8:25 AM ET by Roth Capital

Roth Capital rated Neutral Durata Therapeutics Inc. (NASDAQ: DRTX) on 10/15/2014. Previously Roth Capital rated Buy Durata Therapeutics Inc. (NASDAQ: DRTX) on
03/06/2014., when the stock price was $14.18. Since then, Durata Therapeutics Inc. has gained 67.07% as of 10/15/2014's recent price of $23.69.
If you would have followed the previous Roth Capital's recommendation on DRTX, you would have gained 67.06% of your investment in 223 days.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/15/2014 8:25 AM Hold
23.69 23.00
as of 10/17/2014
1 Week up  0.55 %
1 Month up  70.18 %
3 Months up  62.37 %
1 YTD up  67.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2014 8:25 AM Buy
14.18 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy